Abstract B098: GPX4 is a broadly shared gene vulnerability among residual tumors
Sign Up to like & getrecommendations! Published in 2018 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.targ-17-b098
Abstract: The heterogeneity of tumor cells underlies acquired drug resistance to a variety of therapeutic approaches. The advent of next-generation sequencing has facilitated a wave of studies identifying genetic mutations, which may be preexisting or acquired… read more here.
Keywords: shared gene; drug resistance; drug; broadly shared ... See more keywords